Liquid chromatography/tandem mass spectrometry for the determination of changrolin in rat plasma: application to a bioavailability study

J Pharm Biomed Anal. 2009 Sep 8;50(2):189-93. doi: 10.1016/j.jpba.2009.04.010. Epub 2009 Apr 17.

Abstract

A sensitive and specific LC-CMS/MS method was developed for the quantification of changrolin, an anti-arrhythmic drug, in rat plasma using tiapride as internal standard. Liquid-liquid extraction was employed for sample preparation and analyzed using a multiple reaction monitoring mode with electrospray positive ionization source. The calibration curve for changrolin was linear over the range 5-1600 ng/mL with coefficients of correlation >0.99. The intra- and inter-batch precision was less than 8.6%, and accuracy ranged from 94.6% to 104.5%. This validated LC-MS/MS method was successfully applied to a bioavailability study of oral and intravenous administration of changrolin with 20mg/kg dosage in SD rats.

Publication types

  • Research Support, Non-U.S. Gov't
  • Validation Study

MeSH terms

  • Animals
  • Anti-Arrhythmia Agents / blood*
  • Anti-Arrhythmia Agents / pharmacokinetics
  • Biological Availability
  • Calibration
  • Chromatography, Liquid / methods*
  • Quinazolines / blood*
  • Quinazolines / pharmacokinetics
  • Rats
  • Reference Standards
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Tandem Mass Spectrometry / methods*

Substances

  • Anti-Arrhythmia Agents
  • Quinazolines
  • changrolin